67
Participants
Start Date
January 8, 2007
Primary Completion Date
May 26, 2009
Study Completion Date
May 26, 2009
Low Dose NT-501
Low Dose NT-501 Implanted in study eye and fellow eye received sham surgery
High Dose NT-501
High Dose NT-501 Implanted in study eye and fellow eye received sham surgery
NY University Medical Center, New York
The Hamilton Eye Institute, Memphis
Kellogg Eye Center, Ann Arbor
Retina Foundation of Southwest, Dallas
Retina-Vitreous Associates Medical Group, Beverly Hills
University of Califoria, Davis, Sacramento
University of California, San Francisco, San Francisco
Retina Group of Florida, Hollywood
University of Florida, Jacksonville
University of Minnesota, Minneapolis
Casey Eye Institue, Portland
Lead Sponsor
Neurotech Pharmaceuticals
INDUSTRY